Intra-Cellular Therapies Overview

Intra-Cellular Therapies EBIT

EBIT (Earnings Before Interest and Taxes) analysis for ITCI.

Quarterly EBIT

-$29.20M

↑ 14.37% YoY

As of Dec 31, 2024

Annual EBIT (TTM)

-$116.72M

↑ 26.88% YoY

Trailing 12 months ending Dec 31, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin